Last reviewed · How we verify
NCT01110512
Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI)
Phase 3 trial testing Flavonid in Venous Insufficiency in 140 participants. Status unknown.
1 December 2010
Quick facts
| Lead sponsor | Azidus Brasil |
|---|---|
| Phase | Phase 3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 140 |
| Start date | 1 October 2010 |
| Primary completion | 1 December 2010 |
| Estimated completion | 1 March 2011 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
Conditions studied
- Venous Insufficiency — all drugs for Venous Insufficiency →
Sponsor
Azidus Brasil — full company profile →
Who can join
Adults 18 to 75, any sex, with Venous Insufficiency. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Improvement of the parameters of CVI, such as edema of lower members.
Time frame: 90 days.
There will be 06 planned visits (V0, V1, V2, V3, V4 and V5).
Sponsor's own description
It is hoped that with the use of medication, occurs improvement of the CVI parameters, such as edema, pain, night cramps, functional discomfort, heavy feeling and that the drug test is non-inferior than the comparator.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01110512
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Venous Insufficiency
Currently open trials in the same condition.
- NCT06350695 — The ROle of Compression StocKings in Heart Failure Patients · NA · recruiting
- NCT03250247 — Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial) · NA · active not recruiting
- NCT02397226 — Lower Limb Venous Insufficiency and the Effect of Radiofrequency Treatment Versus Open Surgery · NA · active not recruiting
Other Azidus Brasil trials
Trials by the same sponsor.
- NCT06303635 — Safety of UFRJvac, Trivalent COVID-19 Vaccine · unknown
- NCT06097780 — Efficacy and Safety of NestaCell® in Huntington's Disease · Phase 3 · unknown
- NCT06150833 — Efficacy and Safety and Pharmacokinetics of Boya IVIG · Phase 3 · unknown
- NCT05603403 — Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms · Phase 4 · completed
- NCT05009277 — Study To Evaluate The Sensitivity Of The Linda Thermal Device · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01110512 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azidus Brasil
- Last refreshed: 26 October 2010
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01110512.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing